Study of Embryotoxic and Teratogenic Action of the Medicinal Form of Capsule UROCONITE-0.2 G
Journal: International Journal of Science and Research (IJSR) (Vol.9, No. 5)Publication Date: 2020-05-05
Authors : Ganieva Z.B.; Fayzieva Z.T.;
Page : 1149-1151
Keywords : Uroconite-02 g; embryotoxicity; teratogenicity; fetus; pathology and anomalies;
Abstract
The authors studied the embryotoxic and teratogenic effects of the capsule Uroconite-0.2 g. The results of the study proved that the studied capsule - Uroconite-0.2 g in doses of 100 and 500 mg/kg does not adversely affect the development of the fetus in experimental animals. Therefore, the capsule Uroconite-0.2 g does not involve embryotoxic and teratogenic effects.
Other Latest Articles
- The Denouncement of Family Violence and its Discipline from the Islamic Perspective
- Indexing: As it Gains a New Meaning and Importance in Todays World
- School-Community Partnerships in Bulan District
- Contextual Student Services of Eastern Visayas State University System
- The Image of the Author in the Novel The War is Not a Female Face S. Aleksievich
Last modified: 2021-06-28 17:06:43